LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for InMed Pharmaceuticals and Millions of Other Companies

Sign up for full access to InMed Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Rare Cannabinoid Therapeutics InMed Pharmaceuticals is a global leader in the development and commercialization of rare cannabinoids, positioning the company well to capitalize on the growing demand for cannabinoid-based pharmaceutical drugs across various consumer markets.

Neurodegenerative Disease Focus With a pipeline of therapeutics targeting neurodegenerative diseases like Alzheimer's, InMed Pharmaceuticals has the opportunity to offer innovative treatment alternatives, presenting a strong sales opportunity in the healthcare sector.

Preclinical Program Expansion InMed's continuous launch of new preclinical programs, such as INM-089 for age-related macular degeneration and Alzheimer's, creates avenues for sales growth and partnership opportunities with healthcare providers and researchers seeking novel treatments.

Expert Scientific Advisory Board The appointment of renowned Alzheimer's expert, Dr. David G. Morgan, on InMed's Scientific Advisory Board enhances the company's credibility and provides a solid foundation for engaging with key opinion leaders and potential collaborators in the pharmaceutical industry.

Strategic CFO Appointment The hiring of Netta Jagpal as Chief Financial Officer strengthens InMed Pharmaceuticals' financial stewardship, signaling to potential investors and partners the company's commitment to sustainable growth and efficient business operations.

Similar companies to InMed Pharmaceuticals

✕

Access Insights for InMed Pharmaceuticals and Millions of Other Companies

Sign up for full access to InMed Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

InMed Pharmaceuticals Tech Stack

InMed Pharmaceuticals uses 8 technology products and services including Facebook Pixel, Cloudflare CDN, WordPress, and more. Explore InMed Pharmaceuticals's tech stack below.

  • Facebook Pixel
    Analytics
  • Cloudflare CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • Swiper
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • WP Engine
    Platform As A Service
  • Piwik
    System Analytics & Monitoring
  • Adobe Tag Manager
    Tag Management

Media & News

InMed Pharmaceuticals's Email Address Formats

InMed Pharmaceuticals uses at least 1 format(s):
InMed Pharmaceuticals Email FormatsExamplePercentage
FLast@inmedpharma.comJDoe@inmedpharma.com
44%
First@inmedpharma.comJohn@inmedpharma.com
8%
Last@inmedpharma.comDoe@inmedpharma.com
4%
FLast@inmedpharma.comJDoe@inmedpharma.com
44%

Frequently Asked Questions

Where is InMed Pharmaceuticals's headquarters located?

Minus sign iconPlus sign iconInMed Pharmaceuticals's main headquarters is located at 815 West Hastings, St #310 Vancouver, BC V6C 1B4 CA. The company has employees across 3 continents, including North AmericaSouth AmericaAsia.

What is InMed Pharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact InMed Pharmaceuticals's main corporate office by phone at
✕

Access Insights for InMed Pharmaceuticals and Millions of Other Companies

Sign up for full access to InMed Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-604-669-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is InMed Pharmaceuticals's stock symbol?

Minus sign iconPlus sign iconInMed Pharmaceuticals is a publicly traded company; the company's stock symbol is INM.

What is InMed Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconInMed Pharmaceuticals's official website is inmedpharma.com and has social profiles on LinkedIn.

How much revenue does InMed Pharmaceuticals generate?

Minus sign iconPlus sign icon As of July 2024, InMed Pharmaceuticals's annual revenue reached $3.8M.

What is InMed Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconInMed Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does InMed Pharmaceuticals have currently?

Minus sign iconPlus sign iconAs of July 2024, InMed Pharmaceuticals has approximately 17 employees across 3 continents, including North AmericaSouth AmericaAsia. Key team members include Chief Operating Officer: M. W.Ceo + President, Director: E. A. A.Vice President, Investor Relations And Corporate Communications: C. C.. Explore InMed Pharmaceuticals's employee directory with LeadIQ.

What industry does InMed Pharmaceuticals belong to?

Minus sign iconPlus sign iconInMed Pharmaceuticals operates in the Biotechnology Research industry.

What technology does InMed Pharmaceuticals use?

Minus sign iconPlus sign iconInMed Pharmaceuticals's tech stack includes Facebook PixelCloudflare CDNWordPressSwiperjQuery MigrateWP EnginePiwikAdobe Tag Manager.

What is InMed Pharmaceuticals's email format?

Minus sign iconPlus sign iconInMed Pharmaceuticals's email format typically follows the pattern of . Find more InMed Pharmaceuticals email formats with LeadIQ.
InMed Pharmaceuticals

InMed Pharmaceuticals

Biotechnology ResearchBritish Columbia, Canada11-50 Employees

InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids. Together with our subsidiary, BayMedica, we have unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visit www.inmedpharma.com. Nasdaq: INM

✕

Access Insights for InMed Pharmaceuticals and Millions of Other Companies

Sign up for full access to InMed Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
815 West Hastings, St #310 Vancouver, BC V6C 1B4 CA
Phone number
✕

Access Insights for InMed Pharmaceuticals and Millions of Other Companies

Sign up for full access to InMed Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-604-669-****
Website
inmedpharma.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
INM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $10M

    InMed Pharmaceuticals's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    InMed Pharmaceuticals's revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for InMed Pharmaceuticals and Millions of Other Companies

Sign up for full access to InMed Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.